Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Hyde

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
BMC Bioinformatics|May 8, 2022
An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLsEric B Fauman, Craig Hyde
Journal of Eating Disorders|November 4, 2024
Intolerance of uncertainty and repetitive negative thinking: transdiagnostic moderators of perfectionism in eating disordersCraig Hyde-Smith, Holly Carey, Trevor Steward
Microbial Genomics|June 6, 2023
PfaSTer: a machine learning-powered serotype caller for Jonathan T Lee, Xingpeng Li, Craig Hyde, et al.
Allergy|July 14, 2025
Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With EfficacyLi Xi, Elena Peeva, Yuji Yamaguchi, et al.
The Journal of Rheumatology|July 15, 2023
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving TofacitinibChristina Charles-Schoeman, Craig Hyde, Shunjie Guan, et al.
Scientific Reports|November 17, 2022
A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitisLi Xi, Sandra Garcet, Zhan Ye, et al.
RMD Open|November 2, 2022
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitorsJeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective StudiesA Katrina Loomis, Shaum Kabadi, David Preiss, et al.
Circulation|February 21, 2016
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsKarin Leander, Anders Mälarstig, Ferdinand M Van't Hooft, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
BMC Bioinformatics|May 8, 2022
An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLsEric B Fauman, Craig Hyde
Journal of Eating Disorders|November 4, 2024
Intolerance of uncertainty and repetitive negative thinking: transdiagnostic moderators of perfectionism in eating disordersCraig Hyde-Smith, Holly Carey, Trevor Steward
Microbial Genomics|June 6, 2023
PfaSTer: a machine learning-powered serotype caller for Jonathan T Lee, Xingpeng Li, Craig Hyde, et al.
Allergy|July 14, 2025
Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With EfficacyLi Xi, Elena Peeva, Yuji Yamaguchi, et al.
The Journal of Rheumatology|July 15, 2023
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving TofacitinibChristina Charles-Schoeman, Craig Hyde, Shunjie Guan, et al.
Scientific Reports|November 17, 2022
A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitisLi Xi, Sandra Garcet, Zhan Ye, et al.
RMD Open|November 2, 2022
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitorsJeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2015
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective StudiesA Katrina Loomis, Shaum Kabadi, David Preiss, et al.
Circulation|February 21, 2016
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsKarin Leander, Anders Mälarstig, Ferdinand M Van't Hooft, et al.
Pageof 3